dichloromethyl(triethoxy)silane | CAS:19369-03-0

We serve dichloromethyl(triethoxy)silane CAS:19369-03-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
dichloromethyl(triethoxy)silane

Chemical Name:dichloromethyl(triethoxy)silane
CAS.NO:19369-03-0
Synonyms:(Dichlormethyl)triethoxysilan; Silane,(dichloromethyl)triethoxy; Dichlormethyl-triaethoxysilan; DICHLOROMETHYLTRIETHOXYSILANE;
Molecular Formula:C7H16Cl2O3Si
Molecular Weight:247.19200
 
Physical and Chemical Properties:
Density:1.11;
Index of Refraction:1.436;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥97.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Applicationd as a coupling agent to improve adhesion of organic resins to inorganic surfaces.
It can be used as an intermediate for other functional organosilanes.



Contact us for information like dichloromethyl(triethoxy)silane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DICHLOROMETHYLTRIETHOXYSILANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(Dichlormethyl)triethoxysilan Use and application,Dichlormethyl-triaethoxysilan technical grade,usp/ep/jp grade.


Related News: Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.2-Fluoro-3-iodo-5-methylpyridine manufacturer Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.2-Bromo-5-chloroanisole supplier Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.3-Bromo-2,6-dimethylpyridine vendor Doctors have seen fever, coughing and breathing difficulties, which are all to be expected.Active pharmaceutical ingredients directly impact disease.